Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2018 Aug 17;9:1882. doi: 10.3389/fmicb.2018.01882

Relationship Between Putative eps Genes and Production of Exopolysaccharide in Lactobacillus casei LC2W

Xin Song 1, Zhiqiang Xiong 1, Linghui Kong 1, Guangqiang Wang 1, Lianzhong Ai 1,*
PMCID: PMC6107683  PMID: 30174661

Abstract

Lactobacillus casei LC2W, a probiotic strain, can produce exopolysaccharide (EPS) with anti-hypertensive bioactivity. The relationship between eps genes and EPS synthesis in LC2W due to unclear regulation mechanism of EPS biosynthesis was investigated. The several relevant genes in EPS biosynthetic gene cluster were deleted, overexpressed and complemented. The results suggested that glucose-1-phosphate thymidyltranseferase gene (LC2W_2179), uncharacterized EPS biosynthesis protein (LC2W_2188), and EPS biosynthesis protein (LC2W_2189) were related to EPS biosynthesis. EPS titer decreased 15, 13, and 21% when the three genes were deleted, respectively. When they were overexpressed, EPS titer increased 16, 10, and 18%. When they were complemented, EPS titer was similar to the wild-type strain. This work showed the three eps genes from LC2W played important roles on EPS production.

Keywords: exopolysaccharide, knockout, overexpression, gene complementation, Lactobacillus casei

Introduction

Lactic acid bacteria (LAB) are widespread in natural environment and play an important role in human health. Most of LAB are able to produce exopolysaccharides (EPSs) with a wide structural diversity. These polymers are usually recognized as safe bioactive compounds (Ruas-Madiedo et al., 2006; Mozzi et al., 2009; Mitsuoka, 2014). In recent years, EPSs produced by LAB have received an increasing interest since they might be responsible for several health benefits attributed to probiotic strains, such as immune stimulation, anti-mutagenicity, anti-tumor activity, anti-gastritis, anti-ulcer, anti-virus, cholesterol-lowering properties, blood pressure-lowering activity (Nagaoka et al., 1994; Rodriguez et al., 2009; Kanmani et al., 2011; Fanning et al., 2012; Hidalgo-Cantabrana et al., 2012; Nacher-Vazquez et al., 2015). Moreover, EPS are extensively used in the industrial production of fermented milk and cheese as natural thickeners, stabilizers, emulsifiers, and texturizers (Broadbent et al., 2003; Patel et al., 2012; Ryan et al., 2015). Furthermore, EPSs are also used as food additives and functional food ingredients (Jolly et al., 2002; Welman and Maddox, 2003). However, there is a need to improve the yield of EPSs as well as to explain the biosynthesis mechanism in the LAB.

Over the past few years, EPSs productions from LAB have been improved through mutagenesis breeding and culture conditions optimization (Looijesteijn et al., 2000; Lamothe et al., 2002; Seesuriyachan et al., 2012; Liu et al., 2016). The genes related to EPSs synthesis might be located in plasmids or on the chromosome. In Lactococcus lactis NIZO B40, all the essential genes required for biosynthesis of EPS are in a single 12-kb gene cluster located on a 40-kb plasmid (van Kranenburg et al., 1997). In Streptococcus thermophiles Sfi6, EPS synthesis is associated with a 15.25-kb region encoding 16 open reading frames (ORFs) located on the chromosome (Stingele et al., 1996). Many studies indicated that the yield of EPSs was improved by overexpressing some specific genes or gene cluster. For example, overexpression of a complete eps gene cluster in L. lactis was capable of raising EPS production levels (Boels et al., 2003). Welman et al. (2006) suggested that glucose-6-phosphate may be vital in EPS synthesis. van Kranenburg et al. (1999), also indicated that overexpressed glucosyltransferase could increased EPS production by 15%.

Lactobacillus casei has been used as a health-promoting microbe in fermented food for centuries. It plays an important role in decreasing inflammation, regulating the intestinal microenvironment, and reducing stress-associated abdominal dysfunction in healthy subjects exposed to stressful situations (Aktas et al., 2016; Gleeson et al., 2016; Kato-Kataoka et al., 2016).

Lactobacillus casei LC2W, an EPS-producing strain used in this study, was isolated from traditional dairy products in Inner Mongolia (Ai et al., 2008). Complete genome sequence of LC2W has been finished and a precise effective genetic tool has been proved in L. casei (Chen et al., 2011; Song et al., 2017). Gene knockout, overexpression and complementation mutants were constructed and EPS titer of mutants and wide-type strain were evaluated. The relationship between eps genes and EPS production was explored in this study.

Materials and Methods

Bacterial Strains, Media, and Culture Conditions

Escherichia coli DH5α and Top 10 was used as cloning host. It grew on Luria-Bertani broth (LB) medium (1% (W/V) NaCl, 1% (w/v) tryptone, and 0.5% (W/V) yeast extract) with kanamycin (50 mg/L) at 30°C. All overexpression plasmids were introduced in competent E. coli Top 10 cells grown in LB medium with erythromycin (400 mg/L). L. casei LC2W was cultured in Man, Rogosa, and Sharpe (MRS) medium (each liter of which contained 10.0 g peptone, 10.0 g beef extract, 4.0 g yeast extract, 20.0 g glucose, 1 ml Tween 80, 2.0 g dipotassium hydrogen phosphate, 5.0 g sodium acetate, 2.0 g triammonium citrate, 0.2 g magnesium sulfate, and 0.05 g manganese sulfate) at pH 6.2 and 37°C without shaking (Chen et al., 2014). Erythromycin was used at a concentration of 10 mg/L when necessary. The agar concentration was added at 15 g/L. All recombinant plasmids were introduced into LC2W competent cells by electroporation. The strains used in this study are listed in Table 1.

Table 1.

Plasmids and strains used in this study.

Strains or plasmids Description Source or reference
Strains
L. casei LC2W Wild-type Our lab
E. coli DH 5α Commercial transformation host GIBCO BRL, Life Technologies
E. coli Top 10 Commercial transformation host Takara (Japan)
LC2WΔ2179 LC2W_2179 knockout mutant of LC2W Our lab
LC2WΔ2182 LC2W_2182 knockout mutant of LC2W This study
LC2WΔ2187 LC2W_2187 knockout mutant of LC2W This study
LC2WΔ2188 LC2W_2188 knockout mutant of LC2W This study
LC2WΔ2189 LC2W_2189 knockout mutant of LC2W Our lab
LC2W pIB184-2179 LC2W_2179 overexpression mutant This study
LC2W pIB184-2182 LC2W_2182 overexpression mutant This study
LC2W pIB184-2187 LC2W_2187 overexpression mutant This study
LC2W pIB184-2188 LC2W_2188 overexpression mutant This study
LC2W pIB184-2189 LC2W_2189 overexpression mutant This study
LC2WΔ2179 pIB184-2179 LC2W_2179 complemented mutant This study
LC2WΔ2182 pIB184-2182 LC2W_2182 complemented mutant This study
LC2WΔ2187 pIB184-2187 LC2W_2187 complemented mutant This study
LC2WΔ2188 pIB184-2188 LC2W_2188 complemented mutant This study
LC2WΔ2189 pIB184-2189 LC2W_2189 complemented mutant This study
Plasmids
pLCNICK Genetic edit plasmid Our lab
pLCNICK-2182 Gene knockout plasmid for LC2W_2182 This study
pLCNICK-2187 Gene knockout plasmid for LC2W_2187 This study
pLCNICK-2188 Gene knockout plasmid for LC2W_2188 This study
pIB184 Emr, Lactobacillus–E. coli shuttle vector Our lab
pIB184-2179 Overexpression plasmid for LC2W_2179 This study
pIB184-2182 Overexpression plasmid for LC2W_2182 This study
pIB184-2187 Overexpression plasmid for LC2W_2187 This study
pIB184-2188 Overexpression plasmid for LC2W_2188 This study
pIB184-2189 Overexpression plasmid for LC2W_2189 This study

DNA Manipulation Techniques

PCR amplifications and PCR identifications were performed using the KOD-plus-neo DNA polymerase (Toyobo, Osaka, Japan) or KOD FX polymerase (Toyobo), respectively. Thermo Fisher Scientific (United States) DNA restriction enzymes were used for cloning. Recombinant plasmids were constructed by the ClonExpress MultiS one-step cloning kit (Vazyme Biotech, Co., Ltd., Nanjing, China). Kits of Axygen Biotechnology, Co., Ltd. (Hangzhou, China) were used for extracting plasmids and chromosomal DNA.

All plasmids and oligonucleotides used in this study are listed in Tables 1, 2, respectively. Five genes were chosen as targets: glucose-1-phosphate thymidyltranseferase gene (LC2W_2179), oligosaccharide repeat unit transporter (LC2W_2182), hypothetical gene (LC2W_2187), uncharacterized EPS biosynthesis protein (LC2W_2188), EPS biosynthesis protein (LC2W_2189). LC2WΔ2179 and LC2WΔ2189 have been constructed in the previous study (Song et al., 2017). Knockout plasmids for other three genes (pLCNICK-2182, pLCNICK-2187, and pLCNICK-2188) were constructed by the one-step cloning kit, using follow DNA fragments: the backbone of plasmid pLCNICK-2179 (generated by double digestion by XbaI and ApaI), single guide RNA and homologous arms (Has) cassette (amplified by PCR using corresponding primers). To identify positive clones, colony PCR assays were conducted using a pair of primers for each mutant: the upstream primer of upstream Ha and the downstream primer of downstream Ha.

Table 2.

Oligonucleotides used in this study.

Oligos Sequence (5′→3′)
2182-1-upN ACGGATCACATCTTTTTCTAAACTAGGGCCCCTTAACAACTTCTCTAGGTA
2182-1-downN TAGGTGAACTTAAGGGGGAT
2182-2-upN TTGGAATCCCCCTTAAGTTCACCTACATAAAAATTCTCCAATACC
2182-2-downN GCACCGAGTCGGTGCTTTTTTTGAGTTAGCTTACGTTGGCAGAC
2182gRNAN AAGAAAGGATGATATCACCTCTAGAAAAATAACTGAAACTGTATAGTTTTAGAGCTAGA
2187-1-up ACGGATCACATCTTTTTCTAAACTAGGGCCCTAATTCAGAGACGTCCAAAG
2187-1-down TAAGATTCTCTTTCTTCATGC
2187-2-up ACCTGCATGAAGAAAGAGAATCTTACACGATAGATTCCCCCAA
2187-2-down GCACCGAGTCGGTGCTTTTTTTGAGAATCTGAAAATGAAGAGTCAAAAG
2187gRNA AAGAAAGGATGATATCACCTCTAGAGCTTTGGCAGGTCCTATATTGTTTTAGAGCTAGA
2188-Ha1-upN ACGGATCACATCTTTTTCTAAACTAGGGCCCGATAAAAGGTCCTTGTCATAC
2188-Ha1-downN TAGTAGCTTGTTTTTGAATGC
2188-Ha2-upN TATCCGCATTCAAAAACAAGCTACTACATTTCTATTTTCTCCTTC
2188-Ha2-downN GCACCGAGTCGGTGCTTTTTTTGAGGTCCGTATTTTAGTTAGTTT
2188gRNAN AAGAAAGGATGATATCACCTCTAGATTTGAATTTAAAAGTTCTGAGTTTTAGAGCTAGA
2179-pIB184-up GAAAAATATGAATGACAATGATGTTGGATCCATGCCAGATTTAGCACAG
2179-pIB184-down GCTTATCGATAGATCTCGAGCTCTAGAATTCTTATTTGGCCAATTGCAA
2182-pIB184-up GAAAAATATGAATGACAATGATGTTGGATCCATGAAAGTTATCAAAAACTTTATT
2182-pIB184-down GCTTATCGATAGATCTCGAGCTCTAGAATTCCTATATTCGATTACGAAAGCG
2187-pIB184-up GAAAAATATGAATGACAATGATGTTGGATCCGTGACAGAGAAGCGTAAG
2187-pIB184-down AGCTTATCGATAGATCTCGAGCTCTAGAATTCTTATATTTTTCCATCGATAAATTG
2188-pIB184-up GAAAAATATGAATGACAATGATGTTGGATCCATGAGCTTGAATGGGATT
2188-pIB184-down GCTTATCGATAGATCTCGAGCTCTAGAATTCCTAACGCTCATCGTTACT
2189-pIB184-up TGAAAAATATGAATGACAATGATGTTGGATCCATGAACGAGCAAATCGACC
2189-pIB184-down GCTTATCGATAGATCTCGAGCTCTAGAATTCTCAAATCCGGCGACGGCT
2182yz-up CGGATGAATCACAACCAT
2182yz-down TACGCACCTTTGGTGACT
2187yz-up CAATCAGGTCGAGGTATAC
2187yz-down AACCTATCGCCGGTTTCA
2188yz-up CGACATTTGATCCACTCT
2188yz-down TTAGGGTCATTCTGACGG

To construct overexpression plasmids corresponding to the five target genes, pIB184 was used as the vector with a strong constitutive promoter P23 (Biswas et al., 2008). Plasmid pIB184 was double digested by BamHI and EcoRI. Subsequently, the DNA fragments LC2W_2179, LC2W_2182, LC2W_2187, LC2W_2188, LC2W_2189 (obtained by PCR using corresponding primers) were ligated into the backbone of pIB184 (BamHI and EcoRI), respectively, to generate overexpression plasmids (pIB184-2179, pIB184-2182, pIB184-2187, pIB184-2188, pIB184-2189). The colonies were confirmed by PCR assay, using primers amplified responding genes.

Preparation of Cells for Electroporation

Competent cells of LC2W were prepared as follows. 2 ml of overnight culture was inoculated into 50 ml MRS with 1% glycine added (MRSG) and incubated at 37°C without shaking until the optical density at 600 nm (OD600) reached 0.6 to 0.8. Cells were chilled on ice for 10 min and then harvested by centrifugation at 4,000 ×g, 4°C for 15 min. Cells were washed twice with 30 ml ice-cold 10% glycerol in water, with centrifugation at 5000 ×g and 4°C for 15 min and re-suspended in 0.5 ml ice-cold 10% glycerol in water. One hundred-microliter aliquots of cells were stored at -80°C.

For each electroporation, the competent cells mixed with about 100 ng (for overexpression and complementation) or 1 μg (for knockout) plasmid DNA were transferred into a 4°C precooled 2-mm cuvette (Bio-Rad, United States). Electroporation was performed at 2 kV, 200 Ω and 25 μF, using a Bio-Rad GenePulser Xcell. Then, 900 μl MMRS (MRS with 500 mM sucrose, 20 mM MgCl2, and 2 mM CaCl2) broth was added into the cuvette. The transformed cells were recovered at 37°C for 2–3 h. After that, the recovered cells were plated on MRS (with erythromycin) and incubated for 2–3 days.

Identification of Transformants

The plasmids for gene knockout were delivered into LC2W competent cells by electroporation and cultivated for 48–96 h at 37°C. To identify positive knockout clones, PCR identification was conducted using the primers flanking outside Has on the chromosome. The wild strain LC2W was regarded as control.

To purify mutants and cure plasmids, recombinants LC2W containing different plasmids such as pLCNICK-2182, pLCNICK-2187, pLCNICK-2188 were streaked on MRS medium without erythromycin for about 2–3 times till pure mutants were obtained and plasmids were cured.

To obtained overexpression mutants, the overexpression plasmids were delivered into LC2W competent cells by electroporation, respectively. PCR identification was performed using the primers Em-up/down to identify positive overexpression clones.

The competent cells of gene knockout mutants were prepared and overexpression plasmids were delivered into the responding competent cells to obtained gene complementation clones. To identify positive complementation clones, colony PCR was conducted using the primers, which were used to amply LC2W_2179, LC2W_2182, LC2W_2187, LC2W_2188, LC2W_2189, respectively.

Evaluation of EPS Production

Fermentation was carried out to analyze the EPS production of gene-knockout mutants, gene-overexpression mutants, gene-complementation mutants, and wild-type strain. 2 ml of overnight culture was inoculated into 50 ml MRS broth and incubated at 37°C without shaking for 24 h. The fermentation broth was heated in boiling water for 10 min to inactivate enzymes, and then cooled down to room temperature. Cells and coagulated proteins were removed by centrifugation (10,000 ×g, 4°C, 20 min). EPS was precipitated from the supernatant by adding three times volume of cold ethanol and then stored at 4°C for 24 h. After centrifugation (10,000 ×g, 4°C, 20 min), the precipitate was re-suspended in ultrapure water and dialyzed against water for 72 h (molecular size cut-off: 12,000–14,000 Da). The EPS was evaluated as previously described (Lokman et al., 1997).

Statistical Analysis

All statistical analysis was performed using SPSS software. All data was initially assessed using a one-way ANOVA. All statistically different group are defined as P ≤ 0.05.

Results

In silico Analysis of EPS Gene Cluster in LC2W

In this study, gene cluster which correlated to EPS biosynthesis was hunted down based on surveying the genome sequence of LC2W (Chen et al., 2011). The putative function of each gene was listed in Table 3. Yasuda et al. (2008) reported a unique cluster, which involved in biosynthesis of EPS in L. casei Shirota (Yasuda). The hypothesis EPS cluster from L. casei LC2W was compared with the unique cluster from L. casei Shirota (Figure 1). The cluster of genes from L. casei Shirota, which have been named cps1A, cps1B, cps1C, cps1D, cps1E, cps1F, cps1G, cps1J, determined the synthesis of the EPS. LC2W_2189 and LC2W_2188 were similar to cps1A, cps1B in amino acid sequences, as well as LC2W_2182 was similar to cps1H, and LC2W_2179 was similar to rmlA2. Due to the similarities of the EPS biosynthesis cluster from L. casei Shirota, LC2W_2188 and LC2W_2189 were speculated as EPS biosynthesis protein. In addition, LC2W_2179 was predicted as glucose-1-phosphate thymodyltransferase protein and LC2W_2182 was assumed as oligosaccharide repeat unit transporter protein. All genes mentioned above could regulate the production of EPS according to the blast result. Five genes were chosen to study: LC2W_2179, LC2W_2182, LC2W_2187, LC2W_2188, and LC2W_2189. Four of them were considered involving in EPS biosynthesis. Besides, one of hypothetical genes in the EPS gene cluster (LC2W_2187) was selected for further study because of its unclear characterization in EPS biosynthesis.

Table 3.

Molecular characterization of EPS gene cluster in LC2W.

Open reading frame Product
LC2W_2169 Capsular polysaccharide biosynthesis protein
LC2W_2170 Transcription regulator
LC2W_2171, LC2W_2184, LC2W_2187 Hypothetical protein
LC2W_2172, LC2W_2173, LC2W_2174, LC2W_2175 Transposase
LC2W_2176 dTDP-4-dehydrorhamnose reductase
LC2W_2177 dTDP-glucose 4,6-dehydratase
LC2W_2178 dTDP-4-dehydrorhamnose 3,5-epimerase
LC2W_2179) Glucose-1-phosphate thymidyltransferase
LC2W_2180, LC2W_2181, LC2W_2183, LC2W_2186 Glycosyl transferase
LC2W_2182 Oligosaccharide repeat unit transporter
LC2W_2185 UDP-glucose 4-epimerase
LC2W_2188 Uncharacterized exopolysaccharide biosynthesis protein
LC2W_2189 Exopolysaccharide biosynthesis protein

FIGURE 1.

FIGURE 1

The comparative analysis of EPS gene cluster between LC2W and Lactobacillus casei Shirota.

Construction of a Series of Plasmids and Electroporation

To identify the function of the genes we selected, our previously developed Crispr-Cas9D10A Nickase-assisted genome editing method (Song et al., 2017) was used for gene knockout in L. casei LC2W. A series of plasmids were constructed to develop the gene knockout mutants of target genes (LC2W_2182, LC2W_2187, and LC2W_2188). The positive colonies were confirmed by a 2-kb PCR product. The result of the double digestion by XbaI and ApaI revealed that the cells contained both 12 kb of pLCNICK backbone and 2 kb of Has-sgRNA fragment (Supplementary Figure S1), indicating that the Has-sgRNA had been successfully incorporated into pLCNICK. Sequencing of the plasmids confirmed recombination fragments as expected. The recombination plasmids were named as pLCNICK-2182, pLCNICK-2187, and pLCNICK-2188.

The overexpression plasmids of different genes were constructed to develop the gene overexpression mutants and gene complementation mutants. The positive colonies were confirmed by a 1/1.5 kb PCR product. The result of the double digestion revealed that the cells contained both ∼6 kb pIB184 backbone and the ∼1/1.5 kb gene fragment, indicating that the target gene had been successfully incorporated into pIB184 (Supplementary Figure S2). These overexpression plasmids were named as pIB184-2179, pIB184-2182, pIB184-2187, pIB184-2188, and pIB184-2189.

Construction of Gene Knockout, Gene Overexpression, and Gene Complementation Mutants of Target Genes

The constructed gene knockout plasmids were delivered into LC2W and the gene knockout mutants of LC2W_2187 or LC2W_2188 were confirmed by a 2.2 kb PCR product, which was 1 kb smaller than the wild-type LC2W. Gene knockout mutant of LC2W_2182 was evidenced by a 3.2 kb PCR product, which was 1.5 kb smaller than LC2W (Figure 2). The difference existed between DNA fragments amplified by mutants and wild-type strain consisted with the length of target genes. It implied that the gene knockout mutants (LC2WΔ2182, LC2WΔ2187, and LC2WΔ2188) were constructed successfully using the Crispr-Cas9D10A Nickase-assisted genome editing plasmid (pLCNICK).

FIGURE 2.

FIGURE 2

PCR identification of the gene-knockout mutants. (A) Identification of LC2WΔ2182 mutants. Lane 12 is the wild-type LC2W and others are transformants. The wild-type strain was used as a control. DNA fragments of 4.7 and 3.2 kb correspond to the wild-type and the deletion mutants. (B) Identification of LC2WΔ2187 mutants. Lane 7 is the wild-type LC2W and others are transformants. Lane M, molecular size marker. DNA fragments of 3.2 and 2.2 kb correspond to the wild-type and the deletion mutants. (C) Identification of LC2WΔ2188 mutants. Lane 4 is the wild-type LC2W and others are transformants. DNA fragments of 3.2 and 2.2 kb correspond to the wild-type and the deletion mutant.

The EPS production between overexpression mutant, complementation mutants and wild-type strain should compare to instruct the result of gene knockout further. Gene overexpression plasmids were transferred into competent cells of LC2W. The result of colony PCR assays showed that 700 bp fragments were obtained from LC2W_2179, LC2W_2182, LC2W_2187, LC2W_2188, and LC2W_2189 overexpression transformants. The DNA fragments amplified from transformants were consistent with the size of erythromycin gene. It is shown that gene overexpression mutants (LC2W pIB184-2179, LC2W pIB184-2182, LC2W pIB184-2187, LC2W pIB184-2188, LC2W pIB184-2189) were constructed successfully using the corresponding plasmids.

Construction of gene complementation mutants was the same as above, only the competent cells of the corresponding gene knockout mutants were used. The gene complementation mutants were named as LC2WΔ2179 pIB184-2179, LC2WΔ2182 pIB184-2182, LC2WΔ2187 pIB184-2187, LC2WΔ2188 pIB184-2188, and LC2WΔ2189 pIB184-2189.

Production of EPS by Mutants and Wild-Type

Since the chosen target genes were speculated as the key factors in EPS biosynthesis, the EPS production of mutants and wild strain was compared. As shown in Figure 3, the gene knockout mutants LC2WΔ2179, LC2WΔ2188, and LC2WΔ2189 yield fewer EPS compared with LC2W. EPS production decreased 15, 13, and 21% compared with the wild-type strain, respectively (P ≤ 0.05). The improvement of EPS production of the corresponding gene overexpression mutants (LC2W pIB184-2179, LC2W pIB184-2188, and LC2W pIB184-2189) confirmed the result above. EPS production of these gene overexpression mutants increased 16, 10, and 18% compared with the wild-type strain. The same as LC2WΔ2189 (Song et al., 2017), gene knockout mutant LC2WΔ2188 showed reduced adhesion compared to that of LC2W when cultivated on MRS plate. Moreover, the mutant LC2WΔ2188 had a tendency to coagulate and precipitate in liquid MRS medium. This tendency to coagulate and the precipitate was disappeared in the gene complementation mutant LC2WΔ2188 pIB184-2188 and LC2WΔ2189 pIB184-2189.

FIGURE 3.

FIGURE 3

EPS (exopolysaccharide) production of gene knockout mutants, gene overexpression mutants and gene complementation mutants. The EPS production of wild-type LC2W was used as a control. Asterisk denotes statistical significance (P ≤ 0.05) to control.

There was no significant difference of the EPS production between other gene knockout mutants (LC2WΔ2182 and LC2WΔ2187) and the wild-type strain. These two genes (LC2W_2182 and LC2W_2187) were considered not to be involved in the EPS biosynthesis. The same result of the comparison between the corresponding gene overexpression mutants and wild-type strain was consistent with this conclusion (Figure 3).

Discussion

Exopolysaccharides produced by LAB, are generally recognized as safe (GRAS) food additives. It was reported that EPSs possess beneficial effects on health such as a decrease of blood cholesterol and immune-stimulatory capacities (Hosono et al., 1997; Bleau et al., 2010; Starovoitova et al., 2012). Because of their safe and healthy typical feature, EPSs have received special attention since their potential application in food industry. Some reports focused on the chemical and structural characterization of EPSs and some reviews addressed the health-promoting prebiotic effect of EPS (Salazar et al., 2016). Researchers tried to improved EPS production by genetic and metabolic engineering, but they all chose to overexpress heterogeneous genes due to the lack of efficient genetic tools in LAB. Since an efficient Crispr-Cas9D10A Nickase-assisted genome editing method in L. casei was established (Song et al., 2017), we tried to study the relationship between eps genes and EPS production and regulated EPS production by genetic engineering using the homologous genes.

Yasuda et al. (2008) reported that some genes from a unique cluster were involved in biosynthesis of EPS in L. casei Shirota. The proteins encoded by genes from this unique cluster were predicted and they had similarities to various extents to known proteins involved in biosynthesis of EPS from other LAB (Yasuda et al., 2008). In this study, we have genetically identified a cluster of genes whose products play an important role in EPS biosynthesis in genome of L. casei LC2W. The genome sequence of L. casei LC2W was blasted with L. casei Shirota and a similar cluster was found. Because of the similarity between these two EPS biosynthesis clusters, functions of some genes from the hypothesis cluster were predicted.

To investigate the roles of these genes in EPS production, gene knockout mutants, gene overexpression mutants and gene complementation mutants developed from those five genes were constructed. EPS production of the series mutants and wild-type strain were measured and compared. From the result, EPS production of LC2WΔ2179, LC2WΔ2188, and LC2WΔ2189 decreased compared with the wild-type strain respectively. Corresponding gene overexpression mutants (LC2W pIB184-2179, LC2W pIB184-2188, LC2W pIB184-2189) produce more EPS compared with the wild strain. The EPS production of the complementation mutant LC2WΔ2179 pIB184-2179 was similar with the wild-type strain, the same trend was observed in LC2WΔ2188 pIB184-2188 and LC2WΔ2189 pIB184-2189, which confirmed LC2W_2179, LC2W_2188, and LC2W_2189 were critical in EPS biosynthesis.

LC2W_2188 and LC2W_2189 were assumed as capsular polysaccharide biosynthesis genes, and LC2W_2179 was predicted as nucleotide sugar substrate synthesis gene. The above three genes played important roles in EPS biosynthesis.

Gene knockout mutants LC2WΔ2188 and LC2WΔ2189 showed a tendency to coagulate and precipitate compared to LC2W when cultivated in liquid MRS medium. For this result, we proposed that LC2W_2188 and LC2W_2189 played an important role in EPS biosynthesis. Lack of either of them could cause downtrend of EPS production. They were speculated to cause some changes in the constitution or structure of the EPS, which has been demonstrated to be involved in stabilizing LAB growth (Ruas-Madiedo and de los Reyes-Gavilan, 2005). EPSs are extensively used to improve stability, rheological properties, and texture of food products in food industry because of its hydrocolloid properties (Juvonen et al., 2015). We purposed that lack of LC2W_2188 or LC2W_2189 caused some changes of EPS and decreased its hydrocolloid properties in liquid medium.

Although LC2W_2182 and LC2W_2187 are members of this EPS biosysthesis cluster, their contribution to the EPS production was not apparent. The change of EPS production was not observed in the gene knockout strains (LC2WΔ2182 and LC2WΔ2187) and the corresponding gene overexpression mutants. It implied that LC2W_2182 and LC2W_2187 were not involved in EPS biosynthesis in L. casei LC2W. Further analysis of the function of these genes is needed to clarify the role of each gene product in EPS biosynthesis.

Conclusion

Thirteen mutants related to the five target genes were constructed and evaluated EPS yield. The result showed that LC2W_2179, LC2W_2188, and LC2W_2189 were important in EPS biosynthesis while LC2W_2182 and LC2W_2187 were not involved in this process. At the same time, LC2W_2188 and LC2W_2189 were related to the hydrocolloid properties of LC2W.

Author Contributions

XS performed the experiments and wrote the manuscript. ZX blasted the genes. LK assisted the statistical analysis. GW and LA designed the experiments.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank JiChao Liu for checking the grammar and revising this article.

Footnotes

Funding. This work was supported by the National Natural Science Foundation of China (Award No. 31771956), the “Shu Guang” project supported by Shanghai Municipal Education Commission, Natural Science Foundation of Shanghai (Award No. 18ZR1426800), and the Shanghai Education Development Foundation (Award No. 15SG42).

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2018.01882/full#supplementary-material

FIGURE S1

Identification of the plasmids for gene-knockout mutants. Lanes 1, 2 were the result of colony PCR assays. PCR-amplified fragments 2 kb correspond to Has-sgRNA cassette. Lanes 3–6 were the result of double digestion. Fragments 2 and 12 kb correspond to Has-sgRNA cassette for target genes and the backbone of pLCNICK. Lane M, molecular size marker.

FIGURE S2

Identification of the plasmids for gene-overexpression and gene-complementation mutants. (A) Lanes 1–3, 4–6, 7–9, 10–12 were the result of colony PCR assays for the target genes LC2W_2179, LC2W_2187, LC2W_2188, LC2W_2189. Lane M, molecular size marker. (B) Lanes 1–2 were the result of colony PCR assays for LC2W_2182. (C) The result of double digestion. Fragments 1 and 6 kb correspond to gene fragment and the backbone of pIB184.

References

  1. Ai L. Z., Zhang H., Guo B. H., Chen W., Wu Z. J., Wu Y. (2008). Preparation, partial characterization and bioactivity of exopolysaccharides from Lactobacillus casei LC2W. Carbohydr. Polym. 74 353–357. 10.1016/j.carbpol.2008.03.004 [DOI] [Google Scholar]
  2. Aktas B., De Wolfe T. J., Safdar N., Darien B. J., Steele J. L. (2016). The impact of Lactobacillus casei on the composition of the cecal microbiota and innate immune system is strain specific. PLoS One 11:e0156374. 10.1371/journal.pone.0156374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biswas I., Jha J. K., Fromm N. (2008). Shuttle expression plasmids for genetic studies in Streptococcus mutans. Microbiology 154(Pt 8), 2275–2282. 10.1099/mic.0.2008/019265-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bleau C., Monges A., Rashidan K., Laverdure J. P., Lacroix M., Van Calsteren M. R., et al. (2010). Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW-9595M increase IL-10 production by macrophages. J. Appl. Microbiol. 108 666–675. 10.1111/j.1365-2672.2009.04450.x [DOI] [PubMed] [Google Scholar]
  5. Boels I. C., Van Kranenburg R., Kanning M. W., Chong B. F., De Vos W. M., Kleerebezem M. (2003). Increased exopolysaccharide production in Lactococcus lactis due to increased levels of expression of the NIZO B40 eps gene cluster. Appl. Environ. Microbiol. 69 5029–5031. 10.1128/AEM.69.8.5029-5031.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Broadbent J. R., McMahon D. J., Welker D. L., Oberg C. J., Moineau S. (2003). Biochemistry, genetics, and applications of exopolysaccharide production in Streptococcus thermophilus: a review. J. Dairy Sci. 86 407–423. 10.3168/jds.S0022-0302(03)73619-4 [DOI] [PubMed] [Google Scholar]
  7. Chen C., Ai L., Zhou F., Wang L., Zhang H., Chen W., et al. (2011). Complete genome sequence of the probiotic bacterium Lactobacillus casei LC2W. J. Bacteriol. 193 3419–3420. 10.1128/JB.05017-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen Z., Lin J., Ma C., Zhao S., She Q., Liang Y. (2014). Characterization of pMC 11, a plasmid with dual origins of replication isolated from Lactobacillus casei MCJ and construction of shuttle vectors with each replicon. Appl. Microbiol. Biotechnol. 98 5977–5989. 10.1007/s00253-014-5649-z [DOI] [PubMed] [Google Scholar]
  9. Fanning S., Hall L. J., Cronin M., Zomer A., MacSharry J., Goulding D., et al. (2012). Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl. Acad. Sci. U.S.A. 109 2108–2113. 10.1073/pnas.1115621109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gleeson M., Bishop N. C., Struszczak L. (2016). Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trial. Eur. J. Appl. Physiol. 116 1555–1563. 10.1007/s00421-016-3415-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hidalgo-Cantabrana C., Lopez P., Gueimonde M., de Los Reyes-Gavilan C. G., Suarez A., Margolles A., et al. (2012). Immune modulation capability of exopolysaccharides synthesised by lactic acid bacteria and bifidobacteria. Probiotics Antimicrob. Proteins 4 227–237. 10.1007/s12602-012-9110-2 [DOI] [PubMed] [Google Scholar]
  12. Hosono A., Lee J., Ametani A., Natsume M., Hirayama M., Adachi T., et al. (1997). Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci. Biotechnol. Biochem. 61 312–316. 10.1271/bbb.61.312 [DOI] [PubMed] [Google Scholar]
  13. Jolly L., Vincent S. J., Duboc P., Neeser J. R. (2002). Exploiting expolysaccharides from lactic acid bacteria. Antonie Van Leeuwenhoek 82 367–374. 10.1023/A:1020668523541 [DOI] [PubMed] [Google Scholar]
  14. Juvonen R., Honkapaa K., Maina N. H., Shi Q., Viljanen K., Maaheimo H., et al. (2015). The impact of fermentation with exopolysaccharide producing lactic acid bacteria on rheological, chemical and sensory properties of pureed carrots (Daucus carota L.). Int. J. Food Microbiol. 207 109–118. 10.1016/j.ijfoodmicro.2015.04.031 [DOI] [PubMed] [Google Scholar]
  15. Kanmani P., Satish kumar R., Yuvaraj N., Paari K. A., Pattukumar V., Arul V. (2011). Production and purification of a novel exopolysaccharide from lactic acid bacterium Streptococcus phocae PI80 and its functional characteristics activity in vitro. Bioresour. Technol. 102 4827–4833. 10.1016/j.biortech.2010.12.118 [DOI] [PubMed] [Google Scholar]
  16. Kato-Kataoka A., Nishida K., Takada M., Kawai M., Kikuchi-Hayakawa H., Suda K., et al. (2016). Fermented milk containing Lactobacillus casei strain shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Appl. Environ. Microbiol. 82 3649–3658. 10.1128/AEM.04134-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lamothe G. T., Jolly L., Mollet B., Stingele F. (2002). Genetic and biochemical characterization of exopolysaccharide biosynthesis by Lactobacillus delbrueckii subsp. bulgaricus. Arch. Microbiol. 178 218–228. 10.1007/s00203-002-0447-x [DOI] [PubMed] [Google Scholar]
  18. Liu Q., Huang X., Yang D., Si T., Pan S., Yang F. (2016). Yield improvement of exopolysaccharides by screening of the Lactobacillus acidophilus ATCC and optimization of the fermentation and extraction conditions. EXCLI J. 15 119–133. 10.17179/excli2015-356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lokman B. C., Heerikhuisen M., Leer R. J., van den Broek A., Borsboom Y., Chaillou S., et al. (1997). Regulation of expression of the Lactobacillus pentosus xylAB operon. J. Bacteriol. 179 5391–5397. 10.1128/jb.179.17.5391-5397.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Looijesteijn P. J., van Casteren W. H., Tuinier R., Doeswijk-Voragen C. H., Hugenholtz J. (2000). Influence of different substrate limitations on the yield, composition and molecular mass of exopolysaccharides produced by Lactococcus lactis subsp. cremoris in continuous cultures. J. Appl. Microbiol. 89 116–122. 10.1046/j.1365-2672.2000.01082.x [DOI] [PubMed] [Google Scholar]
  21. Mitsuoka T. (2014). Development of functional foods. Biosci. Microbiota Food Health 33 117–128. 10.12938/bmfh.33.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mozzi F., Gerbino E., Font, de Valdez G., Torino M. I. (2009). Functionality of exopolysaccharides produced by lactic acid bacteria in an in vitro gastric system. J. Appl. Microbiol. 107 56–64. 10.1111/j.1365-2672.2009.04182.x [DOI] [PubMed] [Google Scholar]
  23. Nacher-Vazquez M., Ballesteros N., Canales A., Rodriguez Saint-Jean S., Perez-Prieto S. I., Prieto A., et al. (2015). Dextrans produced by lactic acid bacteria exhibit antiviral and immunomodulatory activity against salmonid viruses. Carbohydr. Polym. 124 292–301. 10.1016/j.carbpol.2015.02.020 [DOI] [PubMed] [Google Scholar]
  24. Nagaoka M., Hashimoto S., Watanabe T., Yokokura T., Mori Y. (1994). Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides. Biol. Pharm. Bull. 17 1012–1017. 10.1248/bpb.17.1012 [DOI] [PubMed] [Google Scholar]
  25. Patel S., Majumder A., Goyal A. (2012). Potentials of exopolysaccharides from lactic Acid bacteria. Indian J. Microbiol. 52 3–12. 10.1007/s12088-011-0148-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rodriguez C., Medici M., Rodriguez A. V., Mozzi F., Font, de Valdez G. (2009). Prevention of chronic gastritis by fermented milks made with exopolysaccharide-producing Streptococcus thermophilus strains. J. Dairy Sci. 92 2423–2434. 10.3168/jds.2008-1724 [DOI] [PubMed] [Google Scholar]
  27. Ruas-Madiedo P., de los Reyes-Gavilan C. G. (2005). Invited review: methods for the screening, isolation, and characterization of exopolysaccharides produced by lactic acid bacteria. J. Dairy Sci. 88 843–856. 10.3168/jds.S0022-0302(05)72750-8 [DOI] [PubMed] [Google Scholar]
  28. Ruas-Madiedo P., Gueimonde M., Margolles A., de los Reyes-Gavilan C. G., Salminen S. (2006). Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. J. Food Prot. 69 2011–2015. 10.4315/0362-028X-69.8.2011 [DOI] [PubMed] [Google Scholar]
  29. Ryan P. M., Ross R. P., Fitzgerald G. F., Caplice N. M., Stanton C. (2015). Sugar-coated: exopolysaccharide producing lactic acid bacteria for food and human health applications. Food Funct. 6 679–693. 10.1039/c4fo00529e [DOI] [PubMed] [Google Scholar]
  30. Salazar N., Gueimonde M., de Los Reyes-Gavilan C. G., Ruas-Madiedo P. (2016). Exopolysaccharides produced by lactic acid bacteria and bifidobacteria as fermentable substrates by the intestinal microbiota. Crit. Rev. Food Sci. Nutr. 56 1440–1453. 10.1080/10408398.2013.770728 [DOI] [PubMed] [Google Scholar]
  31. Seesuriyachan P., Kuntiya A., Hanmoungjai P., Techapun C., Chaiyaso T., Leksawasdi N. (2012). Optimization of exopolysaccharide overproduction by Lactobacillus confusus in solid state fermentation under high salinity stress. Biosci. Biotechnol. Biochem. 76 912–917. 10.1271/bbb.110905 [DOI] [PubMed] [Google Scholar]
  32. Song X., Huang H., Xiong Z., Ai L., Yang S. (2017). CRISPR-Cas9(D10A) nickase-assisted genome editing in Lactobacillus casei. Appl. Environ. Microbiol. 83 e1259-17. 10.1128/AEM.01259-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Starovoitova S. A., Babenko L. P., Timoshok N. A., Shynkarenko L. N., Lazarenko L. N., Spivak N. Y. (2012). Cholesterol-lowering activity of lactic acid bacteria probiotic strains in vivo. Mikrobiol. Z. 74 78–85. [PubMed] [Google Scholar]
  34. Stingele F., Neeser J. R., Mollet B. (1996). Identification and characterization of the eps (Exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6. J. Bacteriol. 178 1680–1690. 10.1128/jb.178.6.1680-1690.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. van Kranenburg R., Boels I. C., Kleerebezem M., de Vos W. M. (1999). Genetics and engineering of microbial exopolysaccharides for food: approaches for the production of existing and novel polysaccharides. Curr. Opin. Biotechnol. 10 498–504. 10.1016/S0958-1669(99)00017-8 [DOI] [PubMed] [Google Scholar]
  36. van Kranenburg R., Marugg J. D., van S., II, Willem N. J., de Vos W. M. (1997). Molecular characterization of the plasmid-encoded eps gene cluster essential for exopolysaccharide biosynthesis in Lactococcus lactis. Mol. Microbiol. 24 387–397. 10.1046/j.1365-2958.1997.3521720.x [DOI] [PubMed] [Google Scholar]
  37. Welman A. D., Maddox I. S. (2003). Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends Biotechnol. 21 269–274. 10.1016/S0167-7799(03)00107-0 [DOI] [PubMed] [Google Scholar]
  38. Welman A. D., Maddox I. S., Archer R. H. (2006). Metabolism associated with raised metabolic flux to sugar nucleotide precursors of exopolysaccharides in Lactobacillus delbrueckii subsp. bulgaricus. J. Ind. Microbiol. Biotechnol. 33 391–400. 10.1007/s10295-005-0075-y [DOI] [PubMed] [Google Scholar]
  39. Yasuda E., Serata M., Sako T. (2008). Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl. Environ. Microbiol. 74 4746–4755. 10.1128/AEM.00412-08 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIGURE S1

Identification of the plasmids for gene-knockout mutants. Lanes 1, 2 were the result of colony PCR assays. PCR-amplified fragments 2 kb correspond to Has-sgRNA cassette. Lanes 3–6 were the result of double digestion. Fragments 2 and 12 kb correspond to Has-sgRNA cassette for target genes and the backbone of pLCNICK. Lane M, molecular size marker.

FIGURE S2

Identification of the plasmids for gene-overexpression and gene-complementation mutants. (A) Lanes 1–3, 4–6, 7–9, 10–12 were the result of colony PCR assays for the target genes LC2W_2179, LC2W_2187, LC2W_2188, LC2W_2189. Lane M, molecular size marker. (B) Lanes 1–2 were the result of colony PCR assays for LC2W_2182. (C) The result of double digestion. Fragments 1 and 6 kb correspond to gene fragment and the backbone of pIB184.


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES